Company attributes
Other attributes
Nirmidas Biotech is a company developing biological testing, assay and imaging technologies in California. Founded 2013 in San Francisco, California, United States by Hongjie Dai and Meijie Tang, Nirmidas Biotech has raised a total of $7M in funding over two rounds. Their latest funding was raised on February 1, 2016 from a Series A round. Nirmidas Biotech is funded by StartX (Stanford-StartX Fund). The company develops, manufactures and markets biological testing, assay and imaging technologies, based on a novel red to near infrared fluorescence enhancing detection platform. It also develops personal and portable diagnostics systems for early disease diagnosis and prognosis monitoring, as well as for population-based screening.

